Biorepository for Cancer Biospecimens to Advance Cancer Care
Official title: ECOG-ACRIN Biospecimen Bank to Support NCTN
Funded at Ecog-Acrin Medical Research Foundation · NIH-11513346 · Data updated 2026-11-12
A national cancer biorepository program will securely collect, store, and share labeled tissue, blood, and other biospecimens from cancer patients to help researchers develop better tests and treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ecog-Acrin Medical Research Foundation NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | April 29, 2015 |
| Project end | March 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $4,164,626 |
| NIH project number | 3U24CA196172-11S1 |
| Project ID | NIH-11513346 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with cancer who contribute samples to the biorepository or whose samples are used for research
✕Less likely to help
Patients whose samples are not selected for research or whose cancer type is not part of the current studies may see no direct benefit
What this research studies
This grant funds the ECOG-ACRIN Central Biorepository and Pathology Facility to standardize how cancer samples are collected and stored. It supports running the biorepository, ensuring high-quality samples, and distributing them to researchers for biomarker and therapeutic studies. The work involves collaboration across NCTN networks, biostatistics, and pathology to enable reliable, shareable biospecimens for future cancer trials. By maintaining well-annotated patient samples, researchers hope to accelerate discovery and translation into better care. The focus is on infrastructure and quality control rather than a single clinical trial.
Why it matters
Potential benefit: If successful, patients with cancer could benefit from faster development of targeted diagnostics and treatments based on high-quality biospecimens.
How similar studies have gone: Similar biorepositories have advanced biomarker discovery and translational research in cancer, with positive impacts on treatment personalization
Where this research is happening
-
Ecog-Acrin Medical Research Foundation
Philadelphia, United States Active
Researchers
- Principal investigator: Jewell, Scott D — Ecog-Acrin Medical Research Foundation
- Study coordinator: Jewell, Scott D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.